对中国医疗保险覆盖辅助生殖技术的可行性分析
Rong Huang1, Jing-Yun Yu2, Wei-Chao He2
1Department of Laboratory, Panyu Hexian Memorial Hospital of Guangzhou, Guangzhou, 511400, China.
Scientific reports
|April 5, 2024
概括
在中国的医疗保险 (MI) 中包括辅助生殖技术 (ART) 是可行的. 覆盖可以提高出生率,并提供投资显著的财务回报,尽管初始成本.
科学领域:
- 生殖医学 生殖医学
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 数以百万计的中国人面临不孕不育,辅助生殖技术 (ART) 的成本是一个重要的障碍.
- 中国的出生率下降加剧了关于将ART纳入医疗保险 (MI) 的辩论.
- 这项研究调查了MI的ART覆盖范围的财务和人口可行性.
研究的目的:
- 评估在中国通过医疗保险 (MI) 覆盖辅助生殖技术 (ART) 的可行性.
- 分析MI覆盖面对人口增长和经济效益的潜在影响.
主要方法:
- 对中国不孕症患病率,ART成本和成功率的元分析.
- 查阅政府公报以获取人口和财务数据.
- 计算潜在的MI支出和投资回报为ART覆盖.
主要成果:
- 在中国,估计有4.102-11.792万对不孕不育的夫妇,每年增加.
- 预计MI支出:最初为72.313-207.878亿元,每年为20.961-32.913亿元.
- 潜力为3.348-9.624万新的活产,显著影响到2050年的人口增长.
结论:
- 由MI覆盖的ART覆盖具有很高的成本效益,金融输入-输出比率为13.022.2.
- 预计,包括心脏病患者在内,会显著提高出生率,到2050年,可能会增加3.7-65亿人.
- 负担得起的成本,经济效益和对人口的积极影响表明,将ART纳入中国MI的可行性.
相关概念视频
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
Infertility in Males
261
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
261
In Vitro Fertilization
255
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
255


